PARP1 and cancer: The idea is by blocking DNA repair pathways through PARP1 inhibitor in BRCA mutated cancers, the DNA damage responses will initiate signaling pathways to promote cell-cycle checkpoint activation, thus apoptosis will be triggered to eliminate cancer cells efficiently [115].